Explore

Trendline Trendline
Dermalogica Launches FDA-Cleared Microneedling Device for Professional Use

Dermalogica Launches FDA-Cleared Microneedling Device for Professional Use

Dermalogica Launches FDA-Cleared Microneedling Device for Professional Use
Trendline Trendline
SetPoint Medical's Neuroimmune Modulation Device Shows Cost-Effectiveness for Rheumatoid Arthritis

SetPoint Medical's Neuroimmune Modulation Device Shows Cost-Effectiveness for Rheumatoid Arthritis

SetPoint Medical's Neuroimmune Modulation Device Shows Cost-Effectiveness for Rheumatoid Arthritis
Trendline Trendline
Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress

Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress

Guided Therapeutics Reports Q1 2026 Financial Results Amid Regulatory Progress
Trendline Trendline
FDA Clears Glooko's EndoTool IV Cloud for Hospital Insulin Dosing

FDA Clears Glooko's EndoTool IV Cloud for Hospital Insulin Dosing

FDA Clears Glooko's EndoTool IV Cloud for Hospital Insulin Dosing
Trendline Trendline
ENDRA Life Sciences Validates TAEUS Liver Device with MRI-like Accuracy

ENDRA Life Sciences Validates TAEUS Liver Device with MRI-like Accuracy

ENDRA Life Sciences Validates TAEUS Liver Device with MRI-like Accuracy
Trendline Trendline
SEEANN Secures Series A Investment to Expand Patient-Specific Implant Production

SEEANN Secures Series A Investment to Expand Patient-Specific Implant Production

SEEANN Secures Series A Investment to Expand Patient-Specific Implant Production
Trendline Trendline
SonoMotion's Break Wave Device Achieves Key Trial Endpoints, Offering New Kidney Stone Treatment Option

SonoMotion's Break Wave Device Achieves Key Trial Endpoints, Offering New Kidney Stone Treatment Option

SonoMotion's Break Wave Device Achieves Key Trial Endpoints, Offering New Kidney Stone Treatment Option
Trendline Trendline
Viz.ai Launches AI-Powered Pulmonary Care Platform to Enhance Patient Outcomes

Viz.ai Launches AI-Powered Pulmonary Care Platform to Enhance Patient Outcomes

Viz.ai Launches AI-Powered Pulmonary Care Platform to Enhance Patient Outcomes
Trendline Trendline
Affinia Therapeutics Unveils Promising AFTX-201 Data for BAG3-Associated Cardiomyopathy at ASGCT 2026

Affinia Therapeutics Unveils Promising AFTX-201 Data for BAG3-Associated Cardiomyopathy at ASGCT 2026

Affinia Therapeutics Unveils Promising AFTX-201 Data for BAG3-Associated Cardiomyopathy at ASGCT 2026
Trendline Trendline
Shyld AI Secures $13.4M to Enhance Autonomous Disinfection in U.S. Hospitals

Shyld AI Secures $13.4M to Enhance Autonomous Disinfection in U.S. Hospitals

Shyld AI Secures $13.4M to Enhance Autonomous Disinfection in U.S. Hospitals
Trendline Trendline
Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026

Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026

Guided Therapeutics Inc Reports No Revenue and Increased Net Loss in Q1 2026
Trendline Trendline
Spruce Biosciences Reports Q1 2026 Financial Results and Strategic Developments

Spruce Biosciences Reports Q1 2026 Financial Results and Strategic Developments

Spruce Biosciences Reports Q1 2026 Financial Results and Strategic Developments